Atossa Genetics Revenue 2012-2023 | ATOS
Atossa Genetics revenue from 2012 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Atossa Genetics Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $1 |
| 2012 | $0 |
| 2011 | $0 |
| Atossa Genetics Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | |
| 2011-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.178B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $209.324B | 25.46 |
| Intuitive Surgical (ISRG) | United States | $130.862B | 78.83 |
| Edwards Lifesciences (EW) | United States | $52.344B | 34.65 |
| DexCom (DXCM) | United States | $50.703B | 87.10 |
| IQVIA Holdings (IQV) | United States | $41.988B | 24.90 |
| IDEXX Laboratories (IDXX) | United States | $39.830B | 47.62 |
| Alcon (ALC) | Switzerland | $39.749B | 29.31 |
| STERIS (STE) | Ireland | $19.852B | 23.50 |
| Hologic (HOLX) | United States | $17.891B | 19.75 |
| Waters (WAT) | United States | $17.747B | 25.47 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.624B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.289B | 84.91 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.059B | 14.89 |
| Sysmex ADR (SSMXY) | Japan | $9.956B | 31.22 |
| Teleflex (TFX) | United States | $9.763B | 15.33 |
| Penumbra (PEN) | United States | $7.857B | 97.13 |
| Masimo (MASI) | United States | $7.107B | 39.86 |
| Globus Medical (GMED) | United States | $6.938B | 22.00 |
| Glaukos (GKOS) | United States | $4.966B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.908B | 24.98 |
| LivaNova (LIVN) | United Kingdom | $2.914B | 19.22 |
| TransMedics (TMDX) | United States | $2.830B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.660B | 18.25 |
| PROCEPT BioRobotics (PRCT) | United States | $2.609B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.368B | 20.03 |
| Integra LifeSciences Holdings (IART) | United States | $2.278B | 9.35 |
| Inari Medical (NARI) | United States | $2.198B | 379.30 |
| Tandem Diabetes Care (TNDM) | United States | $2.049B | 0.00 |
| RxSight (RXST) | United States | $1.936B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.765B | 0.00 |
| Veracyte (VCYT) | United States | $1.490B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.876B | 16.20 |
| OPKO Health (OPK) | United States | $0.857B | 0.00 |
| Artivion (AORT) | United States | $0.837B | 96.76 |
| Paragon 28 (FNA) | United States | $0.812B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.718B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.685B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.682B | 0.00 |
| SiBone (SIBN) | United States | $0.639B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.552B | 18.73 |
| IRadimed (IRMD) | United States | $0.536B | 31.15 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.489B | 0.00 |
| Nevro (NVRO) | United States | $0.450B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.418B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.378B | 0.00 |
| NeuroPace (NPCE) | United States | $0.368B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.348B | 11.72 |
| CVRx (CVRX) | United States | $0.317B | 0.00 |
| AxoGen (AXGN) | United States | $0.300B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.266B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.265B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.251B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.185B | 9.95 |
| 908 Devices (MASS) | United States | $0.184B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.170B | 0.00 |
| Inogen (INGN) | United States | $0.158B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.149B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.140B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.099B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.097B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.086B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 113.00 |
| Vasomedical (VASO) | United States | $0.051B | 9.17 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| InspireMD (NSPR) | Israel | $0.045B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| DarioHealth (DRIO) | United States | $0.039B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.036B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |